No.1 Affiliated Hospital, Medical College of Zhejiang University

Hangzhou 310003

1 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now